Name | Thioredoxin reductase 1 | ||
UniProt ID | TRXR1_HUMAN | ||
Gene Name | TXNRD1 | ||
Gene ID | 7296 | ||
Synonyms |
TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1
|
||
Sequence |
MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLPENPAGFTSTATADSRALLQ
AYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDL PVVFVKQRKIGGHGPTLKAYQEGRLQKLLKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKE AAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKV EETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEK IYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLA GIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVV AQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIY AIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKA VEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQ GFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG |
||
Pathway Map | MAP LINK | ||
KEGG ID | hsa7296 | ||
TTD ID | T84581 | ||
Pfam | PF00070; PF00462; PF00890; PF01134; PF01262; PF01266; PF01494; PF02852; PF03486; PF05834; PF07992; PF12831; PF13450; PF13738 |
Pair Name | Sulforaphane, Selenium | |||
Phytochemical Name | Sulforaphane | |||
Anticancer drug Name | Selenium | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Regulate Info | Up-regulation | Thioredoxin reductase 1 | Expression | |
Result | Combined SFN and Se treatment synergistically upregulated TrxR-1, which plays a significant role in maintaining intracellular redox homeostasis and contributed to the SFN-induced protection against free radical-mediated oxidative damage in normal colonic cells. |
Pair Name | Isodeoxyelephantopin, Cisplatin | |||
Phytochemical | Isodeoxyelephantopin | |||
Drug | Cisplatin | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Regulate Info | Down-regulation | Thioredoxin reductase 1 | Activity | |
Result | Our study provide a preclinical proof-of-concept for ESI as a potential strategy for colon cancer treatment. |
Pair Name | Vitamin K3, Auranofin | |||
Phytochemical | Vitamin K3 | |||
Drug | Auranofin | |||
Disease Info | [ICD-11: 2A00] | Glioblastoma multiforme | Investigative | |
Regulate Info | Up-regulation | Thioredoxin reductase 1 | Expression | |
Result | Our results identify TrxR1 as an attractive drug target and highlights AF as an off-patent drug candidate in GBM therapy. |
Pair Name | Oleanolic Acid, Cisplatin | |||
Phytochemical | Oleanolic Acid | |||
Drug | Cisplatin | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Regulate Info | Down-regulation | Thioredoxin reductase 1 | Expression | |
Result | OLO-2 treatment also exhibited up to 4.6-fold selectivity against human lung adenocarcinoma cells. Taken together, the results of the present study shed light on the drug resistance-reversing effects of OLO-2 in lung cancer cells. |
No. | Title | Href |
---|---|---|
1 | Synergy between sulforaphane and selenium in protection against oxidative damage in colonic CCD841 cells. Nutr Res. 2015 Jul;35(7):610-7. doi: 10.1016/j.nutres.2015.05.011. | Click |
2 | Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells. Front Cell Dev Biol. 2020 Sep 22;8:580517. doi: 10.3389/fcell.2020.580517. | Click |
3 | Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death. Int J Mol Sci. 2022 Dec 11;23(24):15712. doi: 10.3390/ijms232415712. | Click |
4 | Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways. Biochem Pharmacol. 2019;170:113642. doi:10.1016/j.bcp.2019.113642 | Click |